| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Director
3 companies
Barry Richard is a Director at MDXG with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 1 sell.
Estimated insider holdings value: $71.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2019 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 5,000 | $87.49 | $437,454.90 | - | |
| Aug 20, 2019 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 5,000 | $99.32 | $496,592.50 | +0.2% | |
| Aug 14, 2019 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 3,700 | $122.50 | $453,250.00 | +0.1% | |
| Aug 12, 2019 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 1,300 | $122.50 | $159,250.00 | - | |
| Jun 27, 2018 | SRPT Sarepta Therapeutics, Inc. | Director | Sell | 75,000 | $130.34 | $9,775,500.00 | -2.3% | |
| Mar 14, 2016 | SRPT Sarepta Therapeutics, Inc. | Director | Buy | 75,000 | $15.66 | $1,174,185.00 | +2.4% |